AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2026 Issue 1; Section X – New Technology

Intracochlear Administration of DB-OTO

In table XW0, Introduction of Anatomical Regions, substance value 3 DB-OTO via Intracochlear Infusion, and body part value E Ears, were added to approach value 3 Percutaneous, to capture the intracochlear infusion of DB-OTO when it is used to treat congenital hearing loss due to biallelic mutations in the otoferlin (OTOF) gene. DB-OTO delivers a working copy of the OTOF gene into the cochlea.Body Part Approach Device/Substance/Technology Qualifier E Ear(s) 3 Percutaneous 3 DB-OTO via Intracochlear Infusion B New Technology Group 11 ...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.